Skip to main content

Table 1 Bacterial co-infection among the fatal cases of A(H1N1)2009pdm (n = 11)

From: The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09

Author (year)

Study location/ period

Study type

Study population

N (%) autopsied

N (%) hospitalised prior to death

Requirement for

Antiviralsa

n/N (%) any n/N (%) 48 h

Antibioticsb

n/N (%) pre n/N (%) on

n/N (%) during admission

Positive bacterial growth

N (%) bacterial pneumonia

N (%) with S.pneumoniae

Site of isolation

ICU

Mechanical Ventilation

Fajardo-Dolci (2009) [14]

Mexico

16/3/09–16/5/09

Medical record review

N = 100

Consecutive notified hospitalized fatal cases

0/100 (0)

100/100 (100)

NR

84/100 (84.0)

56/100 (56)

NR

94/100 (94)

2/100 (2%)

(Site not mentioned)

77/82 (94.0)

CXR suggestive of pneumonia.

NR

Lee (2010) [1]

USA

4/09–7/09

Enhanced surveillance/confirmed cases in New York City.

N = 47

31/47 (66)

47/47 (100.0)

All 28 cases who died after > 24 in hospital were admitted to ICU

25/47 (80.6)

32/47 (68.0)

NR

NR

NR

13/47 (27.6)

By immunohistochemical analysis or PCR

21/28 with abnormal CXR and multilobar infiltrates.

8/47 (17.0) Lung/airway tissue

By immunohistochemical analysis or PCR

Lucas (2010) [19]

UK

4/09–1/10

Case series.

15% of reported H1N1 deaths

N = 68

Autopsied fatal cases

68/68 (100)

68/68 (100)

NR

NR

NR

NR

20/68 (29.4)

(Culture of lung/ blood)

28/68 (41.2)

- Autopsy findings

- Culture and histopathology

7/68 (10.3)

(6 confirmed and 1 possible through histology) isolation site Lung/ and or blood

Gill (2010) [2]

USA

5/09–7/09

Case series.

Autopsy request New York City (NYC) Office of chief medical examiner (n = 32), family requests (n = 10), deaths outside of NYC (n = 2)

N = 34

Autopsied fatal cases

34/34 (100)

21/34 (61.8)

NR

12/21 (57.1)

NR

NR

10/30 (33.3) Positive bacteria by culture, immunohistochemistry, and/or PCR

18/33 (54.4) have evidence of bacterial co-infection by tissue Gram stain.

6/30 (20) Positive for streptococcus by culture, immunohistochemistry, and/or PCR

16/33 (55) have evidence of bacterial co-infection by tissue Gram stain morphologically compatible with streptococcus.

CDC (2009) [15]

USA

4/09–8/09

Multicenter case series.

100% of reported deaths

N = 36

Pediatric (< 18 yrs).

Hospitalized fatal cases

NR

28/33 (84.8)

24/36 (66.7)

NR

19/30 (63.3)

Status unknown for 6 cases

4/30 (13%)

NR

NR

10/23 (43.5)

Based on culture and pathology results

3/23 (13) from multiple sites in px (BC, lung tissue, pleural fluid, CSF)

Shieh (2010) [18]

USA

5/09–10/09

Notified fatal case series/US CDC

N = 100

Autopsied fatal cases

100/100 (100)

58/87 (66.7)

NR

42/57 (73.7)

44/67 (65.7)

NR

NR

NR

29/100 (29)

Bacterial co-infection positive through PCR and histopathology on lung tissue

38/64 (59) radiological diagnosis of pneumonia

10/100 (10)

Lung tissue through PCR

CDC (2009) [16]

USA

5/09–8/09

Case series (US CDC), multiple (8) states

N = 77

Autopsied fatal cases

77/77 (100)

8/18 (44.0)

NR

7/7 (100.0)

NR

7/9 (77.8)

NR

22/77 (28.6)

Histopathology and positive PCR for bacteria

10/77 (positive through immunohistochemical assays) respiratory tissue

Mauad (2010) [17]

Brazil

7/09–8/09

Case series

N = 21

Autopsied fatal cases

21 (100)

21 (100.0)

16/21 (76.2)

21/21 (100.0)

16/21 (76.2)

NR

13/21 (61.9)

3/9 (33.3)

8/21 (38.1)

6/21 (28.6) diagnosed by culture of bronchial aspirate and/or tissue PCR

Kim (2011) [20]

Korea

8/09–11/09

Active mortality inpatient surveillance

N = 115

Notified hospitalized fatal cases

0/115 (0)

115/115 (100%)

63/115 (54.8)

NR

100/115 (87%)

41/115 (35.6)

NR

34/115 (29.6) positive on blood or sputum culture

34/115 (29.6) positive on blood or sputum culture

97/113 (85.8)

CXR suggestive of pneumonia

3/115 (2.6) bronchoalveolar lavage (BAL)

Streptococcus was also isolated from blood of one case

Nakajima (2012) [21]

Japan

8/09–2/10

Multicenter (15), case series, Tokyo.

N = 20

Autopsied fatal cases

20/20 (100)

11/20 (55.0)

NR

7/20 (35.0)

14/20 (70%)

13/20 (65%)

10/20 (50%)

4/11 (36.4%)

5/20 (25%) Based on histopathological finding (bacteria isolated in 4 of 5)

2/10 (20%)

sputum, blood cultures; lung tissue

Tamme (2012) [22]

Estonia

10/09–5/10

Case series

N = 21

Autopsied fatal cases

19/21 (90)

17/21 (81.0)

15/21(71.4)

NR

3/21 (14.3)

1/21 (4.8%)

16/21 (76.2)

8/21 (38.1)

(Culture performed on 14 samples)

9/21 (42.8)

Culture or Autopsy findings consistent with sepsis or bacterial infection

2/21 (9.5)

Blood and/or lung tissue culture

  1. Antibiotics: time started – “Pre” = started prior admission, “On” = started on admission, “During” = started during admission
  2. Diff Differentiated between bacterial pneumonia, viral pneumonia and ARDS
  3. No diff Did not differentiate between aetiology of abnormal chest imaging
  4. aNumber (percentage) of cases on antivirals; N (%) started within 48 h of symptom onset
  5. bNumber (percentage) of cases on antibiotics commencing pre-admission, on admission or during admission (if reported)